Phospho-heavy-labeled-spiketide faims stepped-cv dda (phased) provides real-time phosphoproteomics data to aid in cancer drug selection

HIGHLIGHTS

  • who: Dilana E. Staudt from the School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia have published the Article: Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection, in the Journal: (JOURNAL)
  • what: In seeking to combine the salient features of these analytical modalities, here the authors report the optimization of a new protocol that employs online phosphoproteome deconvolution in tandem with LFQ in the presence of internal control heavy-labeled standards.
  • how . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?